WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
Johnson & Johnson, Procter & Gamble and other manufacturers are arguing that cough and cold drugs with the pain reliever acetaminophen should stay on the market, in spite of concerns from U.S. regulators.
The FDA is weighing a ban on combination products, which are often marketed to consumers with colds or other mild illnesses. The industry instead urged a widespread effort to warn buyers about the risks of liver damage linked to acetaminophen.